Merck (MRK) Reports Positive Phase III Data For Suvorexant

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. BILL
4. ADI
5. SPY
6. MRK
7. MRNA
8. TJX
9. DE
10. LOW

Go back to Merck (MRK) Reports Positive Phase III Data For Suvorexant
Merck & Co. (NYSE: MRK) Delayed: 150.46 -1.74 (1.14%)
Previous Close $152.20    52 Week High $65.46 
Open $150.78    52 Week Low $47.97 
Day High $151.43    P/E 102.35 
Day Low $148.52    EPS $1.47 
Volume 4,669,274